IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 238 filers reported holding IMMUNOGEN INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,297,532 | +638.8% | 144,772 | +122.2% | 1.06% | +497.2% |
| Q3 2022 | $311,000 | -64.0% | 65,151 | -66.0% | 0.18% | -65.8% |
| Q2 2022 | $863,000 | +133.2% | 191,726 | +146.8% | 0.52% | +121.7% |
| Q1 2022 | $370,000 | +170.1% | 77,694 | +222.5% | 0.24% | +158.2% |
| Q3 2021 | $137,000 | +38.4% | 24,088 | +61.4% | 0.09% | +30.0% |
| Q2 2021 | $99,000 | -18.2% | 14,929 | 0.0% | 0.07% | -22.2% |
| Q1 2021 | $121,000 | -15.4% | 14,929 | -32.4% | 0.09% | -1.1% |
| Q4 2020 | $143,000 | +49.0% | 22,100 | -17.5% | 0.09% | +30.0% |
| Q3 2020 | $96,000 | – | 26,800 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 17,503,417 | $277,779,228 | 13.22% |
| Fairmount Funds Management LLC | 5,929,592 | $94,102,625 | 11.32% |
| CM Management, LLC | 500,000 | $7,935,000 | 8.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,307,435 | $20,748,993 | 6.29% |
| Altium Capital Management LP | 725,000 | $11,505,750 | 6.00% |
| RA Capital Management | 13,322,288 | $211,424,711 | 4.16% |
| TANG CAPITAL MANAGEMENT LLC | 1,500,000 | $23,805,000 | 3.36% |
| BRIDGER MANAGEMENT, LLC | 467,220 | $7,414,781 | 2.73% |
| Birchview Capital, LP | 190,000 | $3,015,300 | 2.57% |
| Boxer Capital, LLC | 2,961,000 | $46,991,070 | 2.50% |